The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Biscayne Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Sanofi; Teva
Research Funding - Bayer; Endocyte; Johnson & Johnson; Progenics; Sanofi; Sotio
Clinical practice patterns of Radium-223 (R223) utilization and variables associated with completion of therapy.
 
Mary-Ellen Taplin
Honoraria - Bayer; Dendreon; Janssen-Ortho; Medivation; Tokai Pharmaceuticals
Consulting or Advisory Role - Bayer; Best Doctors, Inc; Dendreon; Gerson Lehrman Group; Guidepoint Global; Janssen-Ortho; Medivation; Sanofi; Tokai Pharmaceuticals; UpToDate
Research Funding - Bayer; Genentech; Janssen-Ortho; Medivation
Travel, Accommodations, Expenses - Dendreon; Janssen Oncology; Medivation; Tokai Pharmaceuticals
 
Susanna J. Jacobus
No Relationships to Disclose
 
Matthew Fiorillo
No Relationships to Disclose
 
Elisa M. Ledet
No Relationships to Disclose
 
Patrick Cotogno
Research Funding - Bayer (Inst); Dendreon (Inst); Exelixis (Inst); Janssen (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst); Tokai Pharmaceuticals (Inst)
 
Allie E. Steinberger
No Relationships to Disclose
 
Heather A. Jacene
Travel, Accommodations, Expenses - Spectrum Pharmaceuticals
 
Oliver Sartor
No Relationships to Disclose
 
Rana R. McKay
Research Funding - Bayer; Pfizer